Cardiovascular Diseases (CVD)
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Beacon TherapeuticsMA - Cambridge
1 programAssessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
Beacon TherapeuticsAssessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.
Clinical Trials (1)
NCT07401550Beacon TherapeuticsAssessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.
Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.
Start: Dec 2025Est. completion: Dec 2026
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials
1 companies competing in this space